2023-509266-38-00招募中1 期
A study evaluating the safety, tolerability, pharmacokinetics, and activity of RO7566802 given alone and in combination with atezolizumab in patients with locally advanced or metastatic solid tumor malignancies
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 23
- 试验地点
- 6
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
US Program Manager Product Development Regulatory
Scientific
Genentech Inc.
研究点 (6)
Loading locations...
相似试验
招募中
不适用
A study to explore the safety, tolerability, pharmacokinetic profile, and potential efficacy of Guanabenz in patients with early childhood onset Vanishing White Matter (VWM)CACH1002929910012303NL-OMON55425Vrije Universiteit Medisch Centrum40
招募中
不适用
Guanabenz in VWMVanishing White Matter (VWM)Childhood ataxia with central nervous system hypomyelination (CACH)NL-OMON24121Amsterdam University Medical Centers, location VUmc, De Boelelaan 1117, 1081HV Amsterdam30
招募中
1 期
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants with Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies.Systemic Lupus Erythematosus2024-519015-34-00AstraZeneca AB24
已完成
不适用
Investigation of the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple doses of NNC0480-0389 in combination with semaglutide s.c.diabetesNL-OMON55332ovo Nordisk156
尚未招募
1 期
A Study Assessing the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of K-3505 in Healthy Volunteers (PART II)Neurological - Other neurological disordersMigraineACTRN12624001026516KALLYOPE, Inc.12